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Macrophages can fuse to form osteoclasts in bone
or multinucleate giant cells (MGCs) as part of the
immune response. We use a systems genetics
approach in rat macrophages to unravel their genetic
determinants of multinucleation and investigate their
role in both bone homeostasis and inflammatory dis-
ease. We identify a trans-regulated gene network
associated with macrophage multinucleation and
Kcnn4 as being the most significantly trans-regu-
lated gene in the network and induced at the onset
of fusion. Kcnn4 is required for osteoclast and
MGC formation in rodents and humans. Genetic
deletion of Kcnn4 reduces macrophage multinu-
cleation through modulation of Ca2+ signaling, in-
creases bone mass, and improves clinical outcome
in arthritis. Pharmacological blockade of Kcnn4
reduces experimental glomerulonephritis. Our data
implicate Kcnn4 in macrophage multinucleation,
identifying it as a potential therapeutic target for inhi-
bition of bone resorption and chronic inflammation.
INTRODUCTION
Macrophages are versatile and plastic cells that have the ability
to fuse and give rise to multinucleate cells (Chen and Olson,
2005). Macrophage fusion leads to the formation of osteoclasts
in bone and multinucleate giant cells (MGCs) in chronic inflam-
matory diseases (Brodbeck and Anderson, 2009; Helming and1210 Cell Reports 8, 1210–1224, August 21, 2014 ª2014 The AuthorGordon, 2009; Vignery, 2005). Thus, both osteoclasts and
MGCs are derived from the fusion of macrophages. Multinuclea-
tion represents an essential step in osteoclast formation and
activation because mononucleate osteoclasts are unable to
resorb bone efficiently (Helming and Gordon, 2009; Vignery,
2005, 2008) and the genes that are critical for osteoclast activity
are also fundamental to MGC function (Bu¨hling et al., 2001; da
Costa et al., 2005; Yagi et al., 2005; Zhu et al., 2007). Despite
the well-characterized role of osteoclasts in bone homeostasis,
macrophage activation associated with MGC formation in in-
flammatory diseases remains poorly understood.
Genetic studies in mice and humans suggest that germline
sequence variation can regulate macrophage multinucleation
and that this can influence disease pathogenesis. In a murine
model of chronic tuberculosis infection, genetic loci were asso-
ciated with production of inflammatory mediators by macro-
phages (Kramnik et al., 2000; Pichugin et al., 2009), suggesting
the presence of a heritable genetic component affecting MGC
function, which, in turn, mediates susceptibility to granuloma-
tous diseases. In humans, deletions or loss-of-function muta-
tions in either the TYROBP (DAP12) or TREM2 genes are causally
associated with Nasu-Hakola disease (Paloneva et al., 2000,
2002), where defective multinucleation in osteoclasts results in
impaired bone resorption (Humphrey et al., 2004). In addition,
human genome-wide association studies of MGC-associated
diseases such as tuberculosis (Thye et al., 2012) and granuloma-
tosis with polyangiitis (Lyons et al., 2012) identified common
sequence variations associated with these disorders. In rheuma-
toid arthritis (RA), osteoclast differentiation and activation lead to
bone erosion associated with prolonged inflammation (McInnes
and Schett, 2011). However, to date, genetic studies failed to
identify genes and pathways involved in osteoclast activations
resulting from multinucleation. Hence, the key determinants and
molecular pathways of multinucleation in macrophages and the
resulting pathophysiological effects remain largely unexplored.
RESULTS
Identification of a Multinucleation Gene Network in
Macrophages
In order to investigate the genetic components of MGC forma-
tion, we took advantage of strain-specific phenotypic differences
in spontaneous formation of MGCs in the rat, which have not
been described previously. We observed that when bone-
marrow-derived macrophages (BMDMs) from Wistar Kyoto
(WKY) rats and Lewis (LEW) rats are cultured in vitro, WKY mac-
rophages spontaneously form MGCs in contrast with what is
observed in LEW (Figures 1A and S1). These strains have been
widely studied for their differential susceptibility to experimental
glomerulonephritis throughmacrophage activation (Aitman et al.,
2006; Behmoaras et al., 2008, 2010; Page et al., 2012), andWKY
rats also show MGCs in their glomeruli following the induction of
nephrotoxic nephritis (NTN) (Figure S1). These marked pheno-
typic differences suggested genetic determinants of the process
underlying MGC formation in the rat, which we set out to investi-
gate byprofiling genome-wide expression levels inmacrophages
of 200 backcross rats derived from WKY and LEW.
We used mRNA expression level as a quantitative trait to carry
out genome-wide linkage analysis using a panel of single nucle-
otide polymorphisms (SNPs) throughout the rat genome. Using
multivariate Bayesian regression approaches (Bottolo et al.,
2011b), we identified a set of 2,357 transcripts showing signifi-
cant linkages to discrete genetic loci (posterior probability
>80%), which are designated as expression quantitative trait
loci (eQTLs, Figure S2). The majority of transcripts were regu-
lated by local genetic variation forming cis-eQTLs (67%); how-
ever, we also identified many trans-regulated transcripts
(trans-eQTLs) across the rat genome (Figure 1B). As previously
reported (Hubner et al., 2005; Langley et al., 2013), trans-eQTLs
can form clusters that are commonly referred to as trans-eQTLs
hot spots (Breitling et al., 2008) (Table 1). Notably, we identified a
large eQTL hot spot that mapped to three SNPs spanning a
genomic region of 1.2 Mbp located on rat chromosome 9q11,
which regulated in trans the expression of 190 transcripts
(Table 1; Figure 1B). These 190 transcripts formed a gene coex-
pression network, where each gene is regulated in trans by
the same genetic locus (Figure 1C). Cell-type enrichment anal-
ysis using a mouse gene expression atlas showed that the
gene network is enriched for osteoclast genes (enrichment
p value = 4 3 107, Z test for relative overexpression of the
network genes in a tissue/cell type, see Supplemental Experi-
mental Procedures), suggesting a role for the network in macro-
phage multinucleation (Figure 1C). Closer inspection of the
network genes revealed two major determinants of osteoclast
activity (Mmp9 and cathepsin K, reviewed in Helming and Gor-
don, 2009) as well as several reported regulators of macrophage
multinucleation such asP2rx7 (Lemaire et al., 2006),Tm7sf4 (also
known as DC-STAMP [Yagi et al., 2005]), osteopontin (Osp) (Tsai
et al., 2005), Pik3cb (also known as PI3K [Peng et al., 2010]), tet-
raspanin Cd9 (Takeda et al., 2003), and its binding partner Igsf8.CelWe hypothesize that other genes of the large coexpression
network might regulate macrophage multinucleation, therefore
defining a ‘‘Macrophage Multinucleation Network’’ or MMnet.
To prioritize master regulator genes at the rat chromosome 9
locus, we carried out fine mapping analysis and, among others,
identified the Triggering receptor expressed in myeloid cells
(Trem) gene family cluster within the 2-LOD drop support interval
of the peak of linkage (Figure 1D). At this locus, the Trem family
genes showed the strongest cis-acting genetic regulation in
macrophages (variation in gene expression explained by the reg-
ulatory locus; R2 > 0.25, Figures 1E), and, among all genes in the
MMnet, Kcnn4 was the most significant trans-eQTL (Figure 1E).
Quantitative real-time PCR analysis of the expression of the
Trem family genes in backcross macrophages confirmed their
cis-regulation and prioritized Trem2 as the most highly ex-
pressed gene in rat macrophages (>90-fold more expression
compared to all other genes in the Trem cluster, Figure 1F).
Identification of Trem2 as aMaster Genetic Regulator of
the MMnet
We observed a positive correlation between the expression of
Trem2 and 125 (66%) MMnet genes and a negative correlation
between Treml1, D3ZDX3_Rat, Treml2, and the network genes
(Figure 2A). We selected ten genes from the MMnet, including
themost strongly trans-regulated gene (Kcnn4, R2 = 0.25), genes
previously reported to play a role in macrophage multinucleation
(P2rx7 [Lemaire et al., 2006], Tm7sf4 [Yagi et al., 2005], Pik3cb
[Peng et al., 2010], tetraspanin Cd9 [Takeda et al., 2003]) and
additional trans-regulated MMnet genes with varying genetic
effects (R2 ranging from 0.1 to 0.22). These genes recapitulate
the correlation pattern observed between the Trem cluster genes
and the MMnet (Figure 2B). We carried out RNAi experiments to
further prioritize candidates within the Trem gene cluster as po-
tential master regulators of the MMnet, by using small interfering
RNA (siRNA) against Treml1, Trem2, D3ZDX3_Rat, and Treml2
genes that were differentially expressed between WKY and
LEW macrophages (Figure 1F), followed by quantitative real-
time PCR assessment of ten trans-regulated genes from the
network. In keeping with the positive correlation between Trem2
and the MMnet genes (Figures 2A and 2B), we found significant
downregulation of the trans-regulated genes after Trem2
silencing (Figure 2C). On the contrary, silencing of Treml1,
D3ZDX3_Rat, andTreml2 resulted in aweaker andvariabledown-
regulation of the network genes (Figure 2C). This downregulation
was not in accordance with the expected transcriptional
response based on the negative correlation between Treml1,
D3ZDX3_Rat, Treml2, and each trans-eQTL gene expression
(Figure2B). These in vitro experimentsprioritizedTrem2asamas-
ter regulator gene of the MMnet in the rat. We then explored
whether silencing of TREM2 in monocyte-derived macrophages
had a similar effect on the trans-eQTL network genes in humans
(Figure 2D). We showed that there was a significant correlation
between the percentage of knockdown in human MDMs and rat
BMDMs following Trem2 knockdown (Figure 2E). These data
suggest that the Trem2-regulated MMnet genes identified in rat
macrophages are similarly regulated in human macrophages.
Taken together, genome-wide eQTL analysis and in vitro
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Table 1. eQTL Hot Spots Identified in Backcross BMDMs Derived from WKY and LEW
SNP Chr. Position (Mb)
Transcripts Mapping
to Each SNP Five Most Strongly Regulated Genes
Rn34_1071564105 1 71564105 7 RGD1562091 / Zfp61 / Vasp / F1LU75_RAT / Slc26a11
Rn34_1071580649 1 71580649 6 Gemin7l1 / TMED5_RAT / LOC691921 / Kcnn4 / Trove2
Rn34_1084462932 1 84462932 7 F1M372_RAT / D3ZBY1_RAT / Flna / Plek / Fn1
Rn34_1253288627 1 253288627 6 Blnk / LOC689756 / Oasl / Apoc1 / Egr3
Rn34_2146742392 2 146742392 6 RGD1359508 / Dtwd2 / Hrh1 / RGD1561662 / Lce1l
Rn34_2164452465 2 164452465 6 Sucnr1 / Tuft1 / Mgrn1 / Dlgap4 / Ptch1
Rn34_9003266206 9 3266206 29 Phlda1 / Pak6 / Xylt1 / Slc30a1 / RGD1565705
Rn34_9003796216 9 3796216 9 RGD1566226 / D4AE99_RAT / Slc35e4 / RGD1311946 / Hprt1
Rn34_9004824426 9 4824426 15 Plk3 / Capn5 / Bag3 / F1LTZ3_RAT / Ccl22
Rn34_9005917596 9 5917596 7 Tgfb2 / Leprot / RGD1310371 / Creb3l2 / RTN1_RAT
Rn34_9006863573a 9 6863573 40 Tspan7 / Rdh10 / F1LRS4_RAT / Plcd1 / D3ZC56_RAT
Rn34_9007659609a 9 7659609 53 D3ZC56_RAT / D3ZC56_RAT / Ms4a6b / Myo1d / Bend6
Rn34_9008096016a 9 8096016 97 Kcnn4 / Slco4a1 / Flna / Bcat1 / Atp1a3
Rn34_9010210028 9 10210028 6 D4ACH5_RAT / St6gal1 / Myh9 / Plek / E9PU51_RAT
n = 200. eQTL hot spots were defined as significant overrepresentation of trans-eQTLs (i.e., any SNP is associated with more than five transcripts; see
Experimental Procedures).
aSNPs delineate a genomic region of 1.2 Mb linked to the expression of 190 transcripts, which were located elsewhere in the genome and regulated in
trans (i.e., trans-eQTLs).macrophage multinucleation, which is under trans-acting ge-
netic control by the Trem2 gene in rats and humans.
Kcnn4 Is Implicated in Macrophage Multinucleation in
Rodents and Humans
Because multinucleate osteoclasts and MGCs originate from
macrophages (Vignery, 2005), our data suggest that MMnet
controlled by Trem2may contain novel genes regulating macro-
phage multinucleation. We therefore hypothesized that the most
significant trans-eQTL in the network (R2 = 0.25, p = 3.83 1016,
Figure 1E), Kcnn4, encoding an intermediate-conductance cal-
cium-activated potassium channel, regulates multinucleation in
macrophages. Kcnn4 expression peaked during macrophage
multinucleation (Figure S3) and a separate time-dependent
microarray analysis of fusing rat alveolar macrophages and hu-Figure 1. Identification of Kcnn4 within a Genetically Regulated Macro
(A) Genetic determinants of macrophage multinucleation were explored in WKY
fuse spontaneously to formmultinucleate giant cells (MGCs) in vitro and show ama
very few MGCs at day 6 of cell differentiation (original bars, 50 mm).
(B) eQTL analysis of the backcross (BC) BMDMs identifies a unique master regula
shows a single locus regulating the expression of 190 transcripts in trans, sugge
with the corresponding SNP positions are reported in Table 1.
(C) Gene coexpression network of the 190 trans-eQTLs is enriched for osteoclast-
gene in the network is represented as a circle (node), and the fold change in expre
as compared to average expression in other cell types (Supplemental Experime
indicated with thick circles. The edges represent coexpression between the two
(D) Genetic linkage showing the principal component of all the trans-cluster trans
explained by the SNP (R2) >0.2. The 2-LOD drop interval (in red) and the underlying
are according to RefSeq.
(E) The cis-eQTLs within the 2-LOD drop interval (in red) are shown together with t
(R2 > 0.25) and among the trans-eQTLs, Kcnn4 (in blue) is the most significant tr
(F) Quantitative real-time PCR analysis on the positional candidates in BC BMD
zygous, WL). Note that the expression levels of Trem2 are increased at least 90-
Error bars indicate SEM, *p < 0.01. See also Figures S1 and S2.
Celman monocytes revealed Kcnn4 as a differentially expressed
gene, which is strongly induced at the onset of fusion (Figure S3).
We therefore investigated whether Kcnn4 determines multinu-
cleation in osteoclasts and MGCs, two cell types resulting from
multinucleation in physiological and pathological conditions,
respectively. To this aim, we used two selective distinct pharma-
cological blockers (ICA-17043 and TRAM-34) of Kcnn4 in human
and rodent osteoclasts and MGCs and confirmed the effect of
these blockers with targeted gene deletion and RNAi for Kcnn4
(Figure 3). Transfection with siRNA designed against Kcnn4 (Fig-
ure 3A), selective pharmacological blockade (Figures 3B and
3D), and targeted gene deletion (Figure 3C) of Kcnn4 consis-
tently decreasedmacrophagemultinucleation in rodents. Similar
results were obtained in human osteoclasts and MGCs (Figures
3E and 3F), indicating that Kcnn4 regulates macrophagephage Multinucleation Network
and LEW bone-marrow-derived macrophages (BMDMs). WKY macrophages
rked phenotypic differencewhen compared to LEWmacrophages, which form
tory locus on rat chromosome 9q11. Genome-wide distribution of trans-eQTLs
sting master regulation of the trans-eQTL cluster. The detailed eQTL hot spots
expressed genes where the master regulatory locus is highlighted in red. Each
ssion refers to overexpression (blue) or underexpression (green) in osteoclasts
ntal Procedures). Known multinucleation genes (Mmp9, Ctsk, P2rx7, etc.) are
transcripts as identified by ARACNE (Margolin et al., 2006).
cripts (LOD > 10) together with trans eQTLs with variation in gene expression
positional candidates within 2Mb are also shown. The annotated gene names
he trans cluster. Treml1, Trem2,D3ZDX3_Rat, Treml2 are positional candidates
ans-eQTL.
Ms according to their genotype (WKY homozygous, WW; WKY/LEW hetero-
fold when compared to other positional candidates.




Figure 2. Trem2 Is a Master Genetic
Regulator of Macrophage Multinucleation
Network
(A) Heatmap of the correlations between macro-
phage mRNA levels of positional candidates (rows)
and all trans-regulated genes of MMnet, showing
that Trem2 was positively correlated with the
majority (66%) of MMnet transcripts. Red indicates
positive correlation and blue indicates negative
correlations.
(B) Heatmap of the correlations between macro-
phage mRNA levels of positional candidates (rows)
and ten trans-regulated genes representative of
the larger MMnet selected for the siRNA knock-
down experiments in rat BMDMs. Red indicates
positive correlation and blue indicates negative
correlations.
(C) siRNA against Trem2, Treml2, Treml1,
D3ZDX3_Rat in rat macrophages followed by
measurement of 10 transcripts belonging to the
chromosome 9q11 trans cluster by quantitative
real-time PCR. Cd68 and Cd11b expression levels
were assessed as control transcripts that do not
belong to MMnet. Given the correlation patterns
shown in Figure 2B, a one-sample t test was used
to test for directionality of the effect in the tran-
scriptional response. Knockdown of Trem2 led to
significant (50%, p < 0.001) downregulation of all
genes tested, whereas knockdown of Treml2,
Treml1, D3ZDX3_Rat did not result in a significant
alteration in the expression levels of MMnet genes
(p > 0.1 for all MMnet genes tested). At least n = 3
rats were used in each experiments. Error bars
indicate SEM, *p < 0.001.
(D) siRNA-mediated knockdown of TREM2 in hu-
man monocyte derived macrophages (MDMs) and
the quantitative real-time PCR analysis of ten
transcripts from the MMnet. MDMs are from
buffy coats from four healthy donors. Error bars
indicate SEM, *p < 0.05 compared to control
(scrambled).
(E) Knockdown of TREM2 in humanMDMs resulted
in transcriptional downregulation of MMnet genes,
which significantly correlated with downregulation
observed in rat BMDMs (R2 = 0.69, p = 0.005).multinucleation in rodents and humans. The inhibitory effect of
TRAM-34 on macrophage multinucleation is reversible and
TRAM-34 does not affect macrophage differentiation (Figure S3)
but changes the macrophage transcriptome assessed by high-
throughput sequencing of mRNA (RNA-seq, Figure S3). Further-
more, in order to assess whether the absence of Kcnn4 affects
preosteoclast formation, we have quantified TRAP+ mononu-
clear cells isolated from Kcnn4+/+ and Kcnn4/ mice at day 3,
4, and 5 of cell differentiation and showed that early steps of
osteoclast differentiation do not seem to be affected by Kcnn4
deficiency (Figure S3).
Kcnn4 Modulates Bone Turnover
Given our data implicatingKcnn4 in macrophagemultinucleation
and because defects in osteoclast formation impact bone
resorption (Teitelbaum, 2011), we tested whether Kcnn4 defi-1214 Cell Reports 8, 1210–1224, August 21, 2014 ª2014 The Authorciency affects bone mass. Femurs from Kcnn4+/+ and Kcnn4/
female and male mice were analyzed by X-ray, peripheral
quantitative computed tomography (pQCT), and microcom-
puted tomography (microCT). These analyses consistently re-
vealed increased bone mass and density in both female and
male Kcnn4/ mice compared with Kcnn4+/+ mice (Figure 4).
In particular, femurs from Kcnn4/ mice showed increased (1)
X-ray absorption (Figure 4A), (2) total bone mineral density (9%
and 14% increases in females and males, respectively), (3)
trabecular bone density (30% and 29% in females and males),
and (4) trabecular bone volume fraction (27% and 26% in
females and males) (Figures 4B and 4C). Accordingly, Kcnn4/
mice had reduced numbers of TRAP-positive osteoclasts (Fig-
ure S4) and a reduced number of osteoclasts per unit of bone
surface (Figures 4D and S4; Table S1), thus supporting a role





Figure 3. Kcnn4 Regulates Macrophage Multinucleation in Rodents and Humans
(A) WKY BMDMs were cultured in Lab-Tek chambers and incubated with either scrambled or Kcnn4 siRNA, and cells were fixed for the assessment of the
multinucleation. Kcnn4 expression levels were measured by quantitative real-time PCR and normalized to Hprt expression, showing 80% knockdown in
macrophages following incubation with Kcnn4 siRNA (left panel). Silencing of Kcnn4 led to a marked reduction in macrophage multinucleation as the number of
nuclei in macrophages transfected with Kcnn4 siRNA was significantly reduced (right panel) when compared to controls (mean ± SEM; n = 4 rats). Original bars,
50 mm. p < 0.001 determined by Kruskal-Wallis test.
(legend continued on next page)
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mice also displayed increased bone formation and mineral
apposition rates compared with Kcnn4+/+ mice, indicating the
high bonemass phenotype inKcnn4/mice results from effects
on both bone formation and bone resorption (Table S1). We next
investigated whether osteoclast activity was decreased in
Kcnn4/mice in an inflammation-induced calvaria bone resorp-
tion provocation model. This study revealed that Kcnn4/
mice lacked the normal osteoclast-mediated bone resorption
response to inflammation (Figure 4E). We also showed that dele-
tion of Kcnn4 results in reduced osteoclastic resorption in vitro
(Figure S4). Taken together, these data indicate that Kcnn4 par-
ticipates in the control of bone turnover by regulating functional
osteoclast formation and suggest that its effects on bone forma-
tion may be mediated via a primary role in osteoclasts.
Inactivation of Kcnn4 Reduces Severity of
Glomerulonephritis and Bone Erosion in Arthritis
To study the role of Kcnn4 in macrophage multinucleation in
pathological conditions, we used two inflammatory models in
rodents, characterized by MGC and osteoclast activation:
glomerulonephritis and arthritis, respectively. In crescentic
glomerulonephritis (Crgn), we blocked Kcnn4 with its selective
inhibitor TRAM-34 (Wulff et al., 2000) in the WKY NTN model
characterized by glomerular MGCs (Figure S1; Lan et al.,
1998). In the WKY NTN model, the severe and reproducible
glomerular macrophage infiltration following nephrotoxic serum
injection (Tam et al., 1999) is also characterized by approxi-
mately 20% of glomeruli presenting MGCs (Figures 5 and S1).
It is therefore possible to study the effect of TRAM-34 on glomer-
ular MGC formation and renal injury assessed by proteinuria.
TRAM-34 treatment of WKY rats with NTN led to significant
reduction of glomerular crescents, glomerular MGC formation,
and proteinuria without affecting the number of macrophages
infiltrating the glomeruli (Figures 5A and 5B). To evaluate the
role of Kcnn4 in bone erosion in inflammatory arthritis, we
assessed the effect of Kcnn4 deficiency in anticollagen anti-
body-induced arthritis (CAIA) and showed that Kcnn4/ mice
have reduced joint inflammation and tissue damage (Figures
5C, 5D, and S5). Following CAIA serum bone resorption
(CTX) and bone formation (P1NP) markers were measured in
Kcnn4+/+ and Kcnn4/ mice. Kcnn4 deficiency resulted in(B)Whenmacrophages were cultured in the presence of TRAM-34 (10 mM), the num
to cells incubated with the media only (control, basal cells). The results are rep
determined by Kruskal-Wallis test.
(C) BMDMs from 6-week-oldKcnn4+/+ andKcnn4/mice were cultured in the pre
(20 ng/ml) for 4 days to induce the differentiation of osteoclasts (upper panel). Th
osteoclasts per well increased with time in Kcnn4+/+ cells but not in Kcnn4/ cell
0.001) at all time points; the results are representative of three independent expe
(D) Mouse BMDMs were cultured in the presence of M-CSF (25 ng/ml) and RANKL
TRAM-34 and ICA-17043 treatment on mouse osteoclasts reduced the number o
n = 5). Original bars, 100 mm.
(E) Human-monocyte-derived macrophages were cultured in Lab-Tek chambers,
was significantly reduced when cells were incubated with TRAM-34 (10 mM). At le
Original bars, 50 mm. p < 0.001 determined by Kruskal-Wallis test.
(F) Human peripheral blood monocytes were cultured in the presence of M-CS
osteoclasts. Cells were treated with TRAM-34 or ICA-17043 (both 10 mM, left pan
17043 inhibited the formation of monocyte-derived human osteoclasts in a dose
See also Figure S3.
1216 Cell Reports 8, 1210–1224, August 21, 2014 ª2014 The Authorimpaired osteoclastic bone resorption that was not affected by
CAIA but did not affect osteoblastic bone formation (Figure S5).
This is consistent with the results obtained in the lipopolysaccha-
ride (LPS)-induced calvaria model (Figure 4E) showing reduced
osteoclast activity in vivo. Taken together, the results obtained
from the LPS and CAIA experiments suggest that reduced
bone loss in Kcnn4/mice can be attributed to decreased oste-
oclast activity resulting from impaired multinucleation.
Kcnn4 Regulates Ca2+ Signaling in Macrophage
Multinucleation
In order to investigate the mechanism by which Kcnn4 regulates
multinucleation, we focused on intracellular Ca2+ levels because
of the established link between K+ channels and Ca2+ influx dur-
ing lymphocyte activation (Feske et al., 2012). We assessed
whether pharmacological blockade or gene deletion of Kcnn4
results in disturbed Ca2+ signaling and oscillations and revealed
that there are decreased Ca2+ oscillations in Kcnn4/ osteo-
clasts compared to Kcnn4+/+ (Figure 6A). We also detected dif-
ferences between Kcnn4+/+ and Kcnn4/ macrophages in
patch clamp experiments, including a shift in observed reversal
potential following gene deletion or inhibition of Kcnn4 (Fig-
ure 6B). One of the major downstream effects of receptor
activator of nuclear factor kappa-B ligand (RANKL)-induced
activation of Ca2+ signaling is nuclear translocation of dephos-
phorylated nuclear factor of activated T cells, cytoplasmic 1
(NFATc1) (Takayanagi, 2007), and, consistent with this, there
was reduced expression of NFATc1 in Kcnn4/ osteoclasts
(Figure 6C). The reduced NFATc1 expression was associated
with decreased nuclear translocation in Kcnn4/ bone-
marrow-derived macrophages in response to RANKL (Fig-
ure 6D). Similarly, WKY BMDMs treated with TRAM-34 exhibit
reduced Nfatc1 expression associated with decreased multinu-
cleation (data not shown). To elucidate the mechanisms by
which Kcnn4 affects osteoclast differentiation, we stimulated
macrophages with RANKL or LPS for increasing time periods
and found that RANKL-induced p38 and ERK activation were
not modified by Kcnn4 deficiency (data not shown). In contrast,
RANKL-induced Akt activation was reduced (Figure S6). This
result was confirmed in human macrophages treated with
TRAM-34 (Figure S6). Because Akt has been shown to be aber of nuclei per 100macrophageswas significantly reducedwhen compared
resentative of five independent experiments. Original bars, 50 mm. p < 0.001
sence of macrophage colony stimulating factor (M-CSF) (25 ng/ml) and RANKL
e formation of osteoclasts measured as the number of TRAP+ multinucleated
s. Mean ± SD; n = 5; the osteoclast number/well was significantly different (p <
riments. Original bars, 100 mm.
(40 ng/ml) and treated with TRAM-34 or ICA-17043 (both 10 mM, upper panel).
f osteoclasts per well in a dose-dependent manner (lower panel, mean ± SD;
and spontaneous MGC formation was observed in some buffy coats, and this
ast three separate buffy coats were used to differentiate human macrophages.
F (20 ng/ml) and RANKL (10 ng/ml) for 5 days to induce the differentiation of
el). Quantification of osteoclast number per well shows that TRAM-34 and ICA-
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critical mediator of cell proliferation and survival in a variety of
cell types (Scheid and Woodgett, 2001), our results showing
impaired Akt phosphorylation in association with Kcnn4 defi-
ciency suggested that Kcnn4 may regulate apoptosis. Support-
ing this hypothesis, deletion of Kcnn4 was associated with
increased apoptosis in osteoclasts (Figure S6).
DISCUSSION
Using systems genetics approaches, our study demonstrates
how genomic sequence variation affects a unique regulatory
network that is associated with macrophage multinucleation in
the rat. By conducting an eQTL study in the primary macro-
phages of a backcross rat population derived from two inbred
rat strains with contrasting phenotypes (‘‘markedly fusogenic
WKY macrophages’’ versus ‘‘lowly fusogenic LEW macro-
phages’’), we have identified a unique gene regulatory network
(MMnet) associated with macrophage multinucleation in the
rat. We show that Trem2 regulate MMnet, which was enriched
for genes regulating osteoclast formation in the rat, a result
that was confirmed in human macrophages. Consistent with
the previously established role of Trem2 in macrophage fusion
(Helming et al., 2008), activation (Turnbull et al., 2006), and oste-
oclast formation (Cella et al., 2003; Humphrey et al., 2006; Otero
et al., 2012), here, we demonstrate that the strongest trans-eQTL
in the Trem2-controlled gene network, Kcnn4, is a key determi-
nant of macrophage multinucleation in rodent and human oste-
oclasts and MGCs. We independently confirmed the role of
Kcnn4 as a potential modulator of multinucleation by microarray
analysis of fusing rat macrophages and human monocytes that
form osteoclasts. We show that Kcnn4 inhibitors prevent the
formation of monocyte-derived human osteoclasts and MGCs,
in addition to mouse bone-marrow-derived osteoclasts and
rat MGCs.
The intermediate-conductance Ca2+-activated K+ channel
Kcnn4 (also known as Kca3.1 or IK1) is activated in response
to increases in intracellular Ca2+ through calmodulin bound to
its intracellular C terminus (Lam and Wulff, 2011). The blockade
of this channel by a selective small molecule inhibitor (TRAM-34)
was first shown to have immunosuppressive effects on T
lymphocytes (Wulff et al., 2000) and further tested on T cell-
mediated diseases such as inflammatory bowel disease, exper-
imental autoimmune encephalomyelitis, rheumatoid arthritis,
and asthma (reviewed in Lam and Wulff [2011]). AlthoughFigure 4. Kcnn4 Modulates Bone Homeostasis via Osteoclasts
(A) Genetic deletion of Kcnn4 increases bone mass as shown by X-ray analysis p
mice. Note the stronger radio-opacity in femurs from Kcnn4/ mice when comp
(B) Peripheral quantitative computed tomography (pQCT) analysis of femoral bone
8-week-old Kcnn4/ mice compared with Kcnn4+/+ mice (mean ± SD; n = 7–9).
(C) Representative images of microcomputed tomography (microCT) analysis
Kcnn4/ mice. Trabecular bone volume fraction from Kcnn4+/+ and Kcnn4/ fe
(D) Histomorphometry analysis of tibiae from 8-week-old Kcnn4+/+ and Kcnn4/
perimeter (mean ± SD; n = 10).
(E) Microcomputed tomography analysis of calvaria from 8-week-old Kcnn4/ an
LPS on the right calvaria. Mice were sacrificed 5 days later. Note the low abund
Calvarial bone volume fraction, bone thickness and bone density were higher, wh
wild-type (right panel; mean ± SD; n = 5).
See also Figure S4 and Table S1.
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tinucleation has not previously been reported. Treatment with
TRAM-34 improved atherosclerosis in ApoE/ mice aortas
and carotid arteries by decreasing macrophage infiltration and
by possibly inhibiting their migration (Toyama et al., 2008). Simi-
larly, TRAM-34 treatment reduced ED1+ macrophages and
microglia in the rat brain following ischemia/reperfusion stroke
(Chen et al., 2011b), and, more recently, it has been shown
that blockade of Kcnn4 reduced F4/80+ cells in a streptozoto-
cin-induced diabetic mouse model (Huang et al., 2013).
Although it had been reported that Ca2+-activated K+ currents
are involved in the regulation of osteoclast movement and
spreading on bone substrates, and that increase in intracellular
Ca2+ blocks osteoclast bone resorption in vitro (Valverde et al.,
2005), the specific contribution of Kcnn4 in inflammation-
induced osteoclast development in vivo was not previously re-
ported. The effect of Kcnn4 on bone mass is modest compared
to its critical regulatory role in osteoclast and macrophage multi-
nucleation. This is consistent with previous findings demon-
strating a relatively mild effect of macrophage fusion marker
(DC-STAMP) on bone mass (Yagi et al., 2005). At this stage,
the bone formation abnormality observed in Kcnn4/ mice re-
mains incompletely understood and additional studies to inves-
tigate further will require detailed analysis of Kcnn4+/+ and
Kcnn4/ mice at various ages during development and adult-
hood, as well as cell-specific gene targeting approaches
because it was previously used for studying the effect of
cathepsin-k deletion on bone formation (Lotinun et al., 2013).
We also show that Kcnn4 affects macrophage multinucleation
without having an effect on preosteoclast formation, a result pre-
viously documented for Atp6v0d2, a regulator of osteoclast
fusion (Lee et al., 2006). Here, we show that Kcnn4-deficient
mice fail to mount an osteoclastic response to local injection of
LPS into calvaria. Local osteoclast formation and bone loss are
amajor component of the pathogenesis of metabolic and inflam-
matory bone diseases (Boyle et al., 2003). Thus, Kcnn4, which
was previously reported as a potential target for immunosup-
pression (Cahalan and Chandy, 1997; Jensen et al., 2001), auto-
immune diseases (Wulff et al., 2003), and periodontal disease
(Valverde et al., 2005), also represents a potential new target
for the prevention of inflammation-related bone loss.
The WKY NTN model of Crgn is characterized by glomerular
MGC formation (Kaneko et al., 2003) and the renal injury is
entirely dependent on macrophage infiltration and activationerformed on femurs from 8-week-old Kcnn4+/+ and Kcnn4/ female and male
ared with Kcnn4+/+ mice.
s showing total bone density and trabecular bone density of distal femurs from
of distal femurs (left panel) from 8-week-old female and male Kcnn4+/+ and
male and male mice is shown in the right panel (mean ± SD; n = 7–9).
female and male mice showing the number of osteoclasts per trabecular bone
d Kcnn4+/+ male and female mice that had received a 2 ml of injection of 25 mg
ance of resorption lacunae in Kcnn4/ mice when compared with wild-type.











Figure 5. Reduced Severity of Glomerulonephritis and Arthritis by Kcnn4 Inactivation
(A) Glomerular immunohistochemistry showing the effect of specific Kcnn4 blocker TRAM-34 in renal injury in the WKY nephrotoxic nephritis model. Following
nephrotoxic serum injection, glomerular crescents (PAS) and percentage of ED1+ macrophages were assessed in control (vehicle) and TRAM-34-treated rats
(n = 4 rats were used per group of treatment). Original bars, 20 mm.
(B) Quantification of glomerular crescents, proteinuria, percentage of ED1+ cells and number of glomerular MGCs.
(C) Collagen antibody-induced arthritis (CAIA) was induced in 2-month-old male and female Kcnn4/ and Kcnn4+/+ mice (mean ± SD; n = 12–15). Arthritic
severity wasmonitored daily using a visual scoring system as detailed in Supplemental Experimental Procedures. Based on inflammation scoring,Kcnn4 deletion
(legend continued on next page)
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(Aitman et al., 2006; Behmoaras et al., 2008, 2010; D’Souza
et al., 2013; Deplano et al., 2013; Hull et al., 2013; Page et al.,
2012). We show that blocking Kcnn4 in vivo by administration
of TRAM-34 significantly reduces glomerular injury in the WKY
NTN model. Although we did not observe different numbers
of glomerular macrophages between TRAM-34 and vehicle-
treated animals, there was a reduction in glomerular MGCs,
which suggests that Kcnn4 blockade reduced multinucleation
in vivo by preventing disease. In keeping with this, we show
that Kcnn4 deletion leads to a reduced severity in chronic
inflammatory arthritis characterized by osteoclast activation.
Collagen-induced arthritis is characterized by focal collections
of osteoclasts at sites of bone destruction, and previous reports
showed that osteoclast depletion ameliorated bone erosion in
this model (Romas et al., 2002; Sims et al., 2004). Our results
showing reduced bone loss in anticollagen antibody-induced
arthritis in Kcnn4/ mice support these findings. However, the
effect of Kcnn4 deletion in the CAIA model could be driven by
either inflammation or osteoclast-mediated bone erosion/
resorption. Further studies using osteoclast-specific Kcnn4
knockout mice will be crucial in dissecting the relative contribu-
tion of inflammation and osteoclast-driven responses in this
model.
Themeasurements of intracellular Ca2+ reveal thatKcnn4 defi-
ciency reduces the amplitude of Ca2+ oscillations, but not their
frequency, suggesting that K+ currents through the Kcnn4 chan-
nel contribute to the sustained Ca2+ oscillations mainly via the
regulation of membrane potential, rather than Ca2+ mobilization
from intracellular Ca2+ stores. Absence of Kcnn4 appears
to affect several downstream signaling pathways, including
NFATc1 via calcium signaling, and Akt activation, which together
lead to decrease survival of multinucleate macrophages.
In summary, using a systems genetics approach, we identified
a trans-regulated multinucleation network in macrophages and
provided compelling evidence that at least one gene within the
network (Kcnn4) regulates macrophage multinucleation in bone
homeostasis. We also show that Kcnn4 can be effectively tar-
geted to decrease severity of inflammatory conditions character-
ized by MGC or osteoclast activation.
EXPERIMENTAL PROCEDURES
Animals, Genetic Crosses, and Genotyping
Wistar-Kyoto (WKY/NCrl) rats and Lewis (LEW/Crl) were purchased from
Charles River UK. Two hundred Backcross (BC) rats were produced by
breeding WKY with LEW rats (congenic WKY rats were used where the previ-
ously identified crescentic glomerulonephritis QTLs on chromosome 13 and
16 were introgressed from the LEW rats [Behmoaras et al., 2010]). The
(WKY x LEW) F1 animals were backcrossed to the congenic WKY rats. For
genotyping, DNA was isolated from the BC rat spleens using a standard
phenol-chloroform extraction. DNA (250 ng) was used for NspI and StyI frag-
mentation according to Affymetrix SNP6.0 GeneChip instructions. Custom
designed Whole Genome Rat Genotyping arrays (RATDIV arrays, MDC) thatreduced inflammation in males and females, though the prevention was more effi
different between Kcnn4+/+ and Kcnn4/ animals for both genders (p < 0.001).
(D) Histopathomorphometry analysis of the paws and the ankles of Kcnn4+/+ an
parameters (inflammation, pannus, cartilage damage, and bone damage) were c
mice in each group; p < 0.05). Similar results were obtained in male mice (data n
See also Figure S5.
1220 Cell Reports 8, 1210–1224, August 21, 2014 ª2014 The Authorcontain 803,484 SNPs covering the rat genome (based on Rn3.4 version)
were used. SNP calling was performed using the BRLMM algorithm and led
to the identification of 785,247 SNPs with >95% call rate (see Supplemental
Experimental Procedures for additional details). Kcnn4/ mice were gener-
ated on a mixed 129J/C57BL6 background, bred, and genotyped as previ-
ously described (Begenisich et al., 2004). The animals were housed in standard
caging on a 12-hr-light cycle and were offered free access to rodent chow
(Harlan Teklad #2018 Rodent Diet) and water.
Bone X-Ray Radiography, pQCT, microCT, and Histomorphometry
in Mice
Excised femurs were subjected to X-ray using a MX-20 (Faxitron X-ray) at
30 kV for 3 s. X-ray films were scanned using an Epson Perfection 4870.
Bone density was determined as described previously (Ballica et al., 1999)
by Peripheral Quantitative Computed Tomography (pQCT, XCT Research M;
Norland Medical Systems) of a virtual 1 mm cross-section of the distal femur
0.25 mm proximal to the growth plate. In addition, distal femurs were scanned
with a Microcomputed Tomography (microCT) scanner (MicroCT 40; Scanco)
with a 2,048 3 2,048 matrix and isotropic resolution of 12 mm3 voxel size. 3D
trabecular measurements in the secondary spongiosa were made directly, as
previously described (Li et al., 2005). Femurs and tibiae from Kcnn4+/+ and
Kcnn4/ mice were dehydrated in a graded ethanol series and embedded
without decalcification in methylmethacrylate, as we described previously
(Baron et al., 1984). Four-micrometer-thick cross-sections of the distal femur
were stained with Villanueva Mineralized Bone Stain for static histomor-
phometric analysis (see Supplemental Experimental Procedures), whereas
8-mm-thick sections were left unstained for dynamic bone histomorphometric
parameters.
All procedures were approved by the Yale University Institutional Animal
Care and Use Committee. The care and treatment of experimental mice com-
plied with all applicable federal guidelines and was approved by the Institu-
tional Animal Care and Use Committee at Yale University.
Microarray Expression Profiling, eQTL Mapping, and Network
Analysis
Total RNA was extracted from BMDMs from 200 backcross rats using TRIzol
(Invitrogen), and gene expression was measured using Affymetrix 1.0 ST Rat
Gene array. WKY-LEW next-generation sequencing data (Illumina Hiseq
2000) was used to remove SNP-containing probes prior to normalization.
Arrays were normalized using RMA normalization from the Affymetrix package
(Irizarry et al., 2003). Normalization step included Norm-exp background
correction and quantile normalization. Probes signal were summarized at a
transcript level using median polish. The resulting data were log transformed
(Figure S2). Remaining batch effects were removed using ComBat (Chen
et al., 2011a; Johnson et al., 2007) with nonparametric prior. All other param-
eters were left to default. The first two principal components of the normalized
data before and after correcting for batch effects are shown in Figure S2. The
eQTL mapping was performed using ESS++ (Bottolo et al., 2011a, 2011b).
Fixed effects on each individual were added as covariates in the variable
selection process to account for potential outliers or genotyping errors.
eQTL analysis details, network inference, and cell-type enrichment analysis
are described in Supplemental Experimental Procedures.
Nephrotoxic Nephritis in Rats and Collagen Antibody-Induced
Arthritis in Mice
The effect of TRAM-34 on nephrotoxic nephritis (NTN) in the WKY rat was
assessed as follows: eight male WKY rats were injected with the nephrotoxic
serum (NTS) as previously described (D’Souza et al., 2013). A group of four rats
received intraperitoneal injections of TRAM-34 (40 mg/kg) in Miglyol 812cient in female mice. From day 8 onward, the CAIA mean score is significantly
d Kcnn4/ naive and CAIA-induced female mice. All the histomorphometric
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neutral oil (Kemcare) at 1 ml/g, twice a day with 10 hr intervals for 7 days. The
control group (n = 4) had IP injections of Miglyol (vehicle). Rats were killed
7 days following injection of NTS, and glomerular crescents and proteinuria
were measured as previously described (D’Souza et al., 2013). Chronic inflam-
matory arthritis was induced in 8-week-old male and female Kcnn4+/+ and
Kcnn4/ mice by intraperitoneal (i.p.) injection of 7 mg (700 ml) of Arthrogen
monoclonal antibodies (ArthoMAB) blend (Millipore) on day 0. This cocktail
of monoclonal antibodies is directed against epitopes recognized in the
region CB11 of collagen type II. On day 3, 50 mg (<100 ml volume) of LPS
was administered i.p. Beginning on day 4, the animals were monitored daily
for the onset and development of collagen-antibody-induced arthritis (CAIA),
and the injection site on each animal was evaluated for signs of infection,
such as heat, redness, and/or exudation. Mice that felt as ‘‘cold,’’ which likely
underwent cachexia in response to LPS, received subcutaneous injection of
500 ml of warm Ringer solution. Arthritic severity was monitored daily using a
visual scoring system (Supplemental Experimental Procedures). The histo-
pathological evaluation of CAIA is described in Supplemental Experimental
Procedures.
ACCESSION NUMBERS
The ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) accession number for
the rat-bone-marrow-derived macrophage microarray data reported in this
paper is E-MTAB-2719.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
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Figure S1. Related to Figure 1. WKY macrophages fuse spontaneously to form multinucleated giant cells 
in vitro and during crescentic glomerulonephritis. (A) BMDMs from NTN-susceptible WKY and NTN-
resistant LEW rats were cultured and cells were fixed at different time points (Day 2 to Day 6). Total RNA 
was extracted at Day 2, Day 4 and Day 6 to assess Mmp-9 expression as readout of macrophage giant cell
formation by qRT-PCR. Original bars = 25 μm (B) Actin cytoskeleton (phalloidin) in spontaneously formed 
multinucleated giant cells in WKY BMDMs  (nuclei staining: DAPI, original bars = 50 μm). (C) CD68 (ED-
1) staining of a WKY glomerulus showing multinucleated ED1+ giant cells following the induction of NTN 
(day 10); original bars = 25 μm. Error bars indicate SEM. C 
Multinucleated 
CD68+  giant cell 
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Figure S2 Figure S2. Related to Figure 1. eQTL analysis in the BMDMs derived from 200 back-cross rats. (A) 
Boxplots of expression data before and after normalization. Boxplots of log2-transformed expression data 
before (left panel) and after (right panel) RMA normalization, respectively. Each boxplot corresponds to 
one sample. Samples are shown in processing order. (B) Position of individual BC rats on first two 
principal components (PC) of the genome-wide expression data, before (left panel) and after (right panel) 
batch-effect corrections. Each rat is designated by a number corresponding to the batch it was processed. 
Parental congenic rats were culled and processed together with the rest of the BC rats controls (one for 
each batch) and  they are shown in red. (C) Imputation of the missing genotypes in the BC population 
(n=200). All three panels represent a fraction of chromosome 20 genotype data in BC rats, where each 
row represents a SNP and each column represents an individual BC rat. Blue and red cells represent 
homozygous WKY-WKY and WKY-LEW heterozygous genotypes respectively, whereas white cells 
indicate missing genotypes. Genotyping data before (left panel) and after imputation (right panel) are 
shown. Genotyping errors were corrected in the lower panel. Imputation fills each missing value with the 
most likely genotype according to surrounding haplotype whereas genotype correction  replaces isolated  
genotype calls according to their haplotypic context. (D) Average fraction of Lewis DNA in the 
population across the genome. 2D density plot of LEW allele frequency in the BC population according to 
genomic position, based on the 278,124 SNPs where the WKY genome differs from LEW. For the largest 
majority of SNPs, the frequency of LEW allele is close to 25%, consistent with the chosen back-cross 
strategy. SNPs where the frequency differs significantly from 0.25 reflect either congenics regions (see 
Methods), or failure of the genotype calling algorithm (isolated dots). All these SNPs were not taken into 
account for the eQTL analysis. (E) Heatmap of Identity by Sharing (IBS) in the WKY x LEW back-cross 
population. The normal distribution of IBS around 0.5 is consistent with the distribution expected under 























































































% of CD68+ cells (Control) 
% of CD68+ cells (TRAM34) 
D2 D3 D4 D5 D6 D7 D8 
98 98 99 100 98 97 100 















Log(FC)  P-value  FDR  Gene symbol 
-1.23  1.45 x 10-71  2.17 x 10-67  Abcg1   
-1.71  2.82 x 10-71  2.17 x 10-67  Serpinb2 
-1.34  2.17 x 10-57  1.12 x 10-53  Scd 
-1.00  1.60 x 10-54  6.19 x 10-51  Abca1 
-1.38  1.25 x 10-51  3.86 x 10-48  Alpk2 
-0.92  5.57 x 10-45  1.43 x 10-41  Irg1 
-0.80  1.27 x 10-43  2.79 x 10-40  Slamf6 
-1.28  4.31 x 10-42  8.32 x 10-39  P97600_RAT 
-1.10  5.36 x 10-42  9.18 x 10-39  Marcksl1 
-1.17  6.24 x 10-42  9.63 x 10-39  Olr1 
-1.31  2.91 x 10-39  4.08 x 10-36  E9PSM5_RAT 
-1.22  8.49 x 10-39  1.09 x 10-35  Mfng 
-0.91  1.09 x 10-38  1.29 x 10-35  Cd8a 
-2.47  4.61 x 10-38  5.08 x 10-35  LOC689963 
-1.33  2.35 x 10-33  2.42 x 10-30  Kit 
-1.02  4.74 x 10-32  4.57 x 10-29  Nrxn2   
-2.46  1.94 x 10-31  1.76 x 10-28  Ccl6 
-1.58  2.67 x 10-30  2.29 x 10-27  Mylip 
-0.62  1.86 x 10-29  1.51 x 10-26  Malt1 
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Figure S3 Figure S3. Related to Figure 3. Kcnn4 expression is induced at the onset of macrophage fusion; Kcnn4 
blockade is reversible and its genetic deletion does not affect pre-osteoclast formation. (A) Total RNA 
was extracted at Day 1 until Day 7 to assess Kcnn4 expression by qRT-PCR in progressively 
multinucleating WKY BMDMs. Note the peak of Kcnn4 expression at day 4 in both strains and the 
relative increase in the fusion-competent WKY BMDMs. Relative expression values were normalised to 
Hprt expression.  Error bars indicate SEM. (B) Total RNA was isolated from fusing rat alveolar 
macrophages (n=4) and subjected to Affymetrix Genechip analysis at different time points (0h, 1h, 24h, 
5 days). Mean signal probe-set intensities are shown for rat Kcnn4. (C) Human monocyte-derived 
macrophages were cultured in the presence of M-CSF (20 ng/ml) and RANKL (10 ng/ml) for the 
indicated times to induce osteoclast differentiation and subjected to Affymetrix Genechip analysis. 
Mean signal probe-set intensities are shown for human Kcnn4. **, P < 0.001 when compared to 0h; 
error bars indicate SEM.	   
 
Figure S3 Figure S3. Related to Figure 3. (D) Bone marrow-derived macrophages from WKY rats were 
cultured at indicated times and incubated with TRAM-34 (10 µM) at day 3 (D3) where 
multinucleation occurs. TRAM-34 was then withdrawn from the culture media and the number of 
MGCs/well were determined as the number of cells containing > 10 nuclei at day 4 onwards. The 
lower panel shows the quantification of MGCs from D4. ns, non significant; *, P < 0.05; **, P < 
0.01; ***, P < 0.001 when compared with TRAM-34 (D4). (E) % of CD68+ cells quantified by 
counting ED-1+ (rat CD68) cells during macrophage differentiation in control and media 
supplemented with TRAM-34. (F) RNA-seq analysis following selective pharmacological 
blockade of Kcnn4. The table shows the top 20 differentially expressed genes between WKY 
BMDMs treated with TRAM-34 (10 µM) when compared with untreated ones.  FDR, False 
Discovery Rate; FC, fold change. (G) Tissue enrichment analysis of all the differentially 
expressed genes between control and TRAM-34 treated cells. (H) Bone marrow-derived 
macrophages from 6-week old Kcnn4+/+ and Kcnn4-/- mice were cultured in the presence of M-
CSF (25 ng/ml) and RANKL (20 ng/ml) for 2, 3 and 4 days to induce the differentiation of 
osteoclasts (Bar =100 µm, left panel). TRAP+ mononuclear cells (pre-osteoclasts) were quantified 
at each day during differentiation and the number of TRAP+ pre-osteoclasts/well reported (TRAP
+ pOCs/well). When the fusion outcome was measured as the number of large TRAP+ 
multinucleated  cells (TRAP+ MNCs/well), there was a marked reduction in these cells in Kcnn4-/- 

























































Kcnn4+/+ Kcnn4-/- Figure S4. Related to Figure 4. Kcnn4 affects osteoclast formation and activity. (A) Representative 
TRAP staining images of proximal tibiae from 8-week old Kcnn4+/+ and Kcnn4-/- female and male 
mice. Note the reduced TRAP+ osteoclasts (in red) in male and female Kcnn4-/- mice tibiae.  Arrows 
show the TRAP+ red staining in Kcnn4+/+ mice. Original bar = 50µm. (B) Representative images of 
tibial bone sections for histomorphometry (static, upper two panels; dynamic, lower two panels; 8-
week-old Kcnn4+/+ and Kcnn4-/- female and male mice). (C-D) Histomorphometry analysis of 
Trabecular Area (C) and Trabecular Number (D). Data are reported as mean±SD (n=10 mice). (E) 
Mouse bone-marrow-derived macrophages were cultured in the presence of M-CSF (20 ng/ml) and 
RANKL (40 ng/ml) on calcium phosphate substrate coated chambers and treated with Kcnn4 
inhibitors, TRAM-34 or ICA-17043. Graphs show quantitation data for the number of resorption pits 
per well (left panel) and the resorbed area per well (right panel). Error bars indicate SD. (F, G) Bone-
marrow-derived macrophages from Kcnn4+/+ and Kcnn4-/- mice were cultured in the presence of M-
CSF (20 ng/ml) and RANKL (40 ng/ml) on calcium phosphate substrate coated chambers. (F) 
Representative images displaying resorption pits by osteoclasts. (G) Quantitation data for the number 




































P < 0.001 
P < 0.001 
!"
#"Figure S5. Related to Figure S5. Deletion of Kcnn4 reduces anti-collagen antibody-induced bone erosion 
in chronic inflammatory arthritis. (A) Representative micrographs of the fore paws from Kcnn4+/+ and 
Kcnn4-/- female  (upper panel) and male (lower panel ) naïve and CAIA-induced  mice. Small arrows point 
out representative normal joints. Red arrows point out areas of subchondral bone resorption. W = wrist. 
Note the severe inflammation and cartilage damage with moderate pannus and bone resorption in joints of 
CAIA-induced Kcnn4+/+ mice. This is in contrast with naïve and CAIA-induced  Kcnn4-/- mice, which show 
no and minimal inflammation and cartilage damage, respectively. (B) Measurement of serum markers of 
bone formation (P1NP) and bone resorption (CTX) in control (naïve) and following CAIA induction in 
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A Figure S6. Related to Figure 6. AKT activation in the absence of Kcnn4 in macrophages and the effect of 
Kcnn4 deficiency on apoptosis in osteoclasts.  (A) Western Blot analysis of BMDMs isolated from Kcnn4+/+ 
and Kcnn4-/- mice were cultured in the presence of M-CSF (25 ng/ml) and RANKL (40 ng/ml) for 4 days, 
then cultured in the presence of M-CSF alone, with or without RANKL (40 ng/ml) or LPS (100 ng/ml) for 
the indicated times. Note the decrease in Akt (Ser473) phosphorylation in Kcnn4-/- macrophages treated with 
RANKL when compared with Kcnn4+/+. Human monocyte-derived macrophages were pre-treated with 
TRAM-34 (10 mM) for 40 minutes and then stimulated with RANKL (100 ng/ml) for the indicated times. 
Similarly TRAM-34 prevented activation of Akt in human osteoclasts. These experiments were repeated 3 
times with similar results and representative blots are shown. (B) Bone marrow derived macrophages from 
Kcnn4+/+ and Kcnn4-/- mice were cultured in presence of M-CSF (25ng/ml) and RANKL (10ng/ml) for 4 days 
to induce the differentiation of osteoclasts. Cell were then incubated in serum and ligand (M-CSF/RANKL)-
free media for 12 hours to induce apoptosis. TUNEL positive (dark brown colour) is observed in the nuclei 
of multinucleated osteoclasts that are undergoing apoptosis (upper panel). Following quantification, 
osteoclasts from Kcnn4-/- mice contained significantly more TUNEL-positive nuclei when compared to 
osteoclasts from Kcnn4+/+ mice (lower panel). Error bars indicate SD. 
 Table S1. Related to Figure 4. Histomorphometric analysis of proximal tibiae from Kcnn4+/+ and Kcnn4-/- mice. See extended protocols for the 








Extended experimental procedures 
Reagents 
Rabbit polyclonal antibodies directed against p-38, phosphorylated-p38 (Thr180/Tyr182), 
p42/44MAPK , phosphorylated -p42/44MAPK (Thr202/Tyr204), Akt, phosphorylated –Akt 
(Ser473), CREB, phosphorylated -CREB (Ser133) were obtained from Cell Signaling 
Technology (Beverly, MA). A rabbit polyclonal antibody directed against the intracellular 
domain of MFR was published previously (Han et al., 2000). A rabbit polyclonal antibody 
directed against c-Fos, and a mouse monoclonal antibody directed against NFATc1 were 
purchased from Santa Cruz (Santa Cruz, CA). Rat monoclonal antibodies directed against 
mouse CD200 and CD44 were purchased from AbD Serotec (Kidlington, UK) and BD 
Biosciences (San Diego, CA), respectively. Mouse anti-GAPDH was purchased from 
Ambion (Austin, Texas). Horseradish peroxidase-conjugated F(ab’)2 from goats directed 
against rabbit, rat and mouse IgG were purchased from Jackson ImmunoResearch (West 
Grove, PA). Phalloidin-Alexa fluor 568 and Tropo-3 was purchased from Invitrogen 
(Carlsbad, CA) and Osteologic slides from BD (Franklin Lakes, NJ). All supplies and 
reagents for tissue culture were endotoxin-free. Unless otherwise stated, all chemicals were 
from Sigma Chemical Co. (St Louis, MO). The Kcnn4 inhibitors, TRAM-34 and ICA-17043, 
were dissolved in 100% DMSO, and the final concentration of DMSO in culture was 0.1%, 
independent of the concentration of the inhibitors. 
Genotype cleaning and imputation  
The distribution of haplotype length shows a great overrepresentation of single SNP 
haplotypes. This overrepresentation can be attributed to genotyping errors that occur 
randomly in an independent manner. Thus isolated single SNP haplotype are likely to be 
caused by genotyping errors rather than true recombination events. Therefore, we reversed 
the genotype calling for all single SNP haplotype surrounded by 2 haplotypes of length 	   1	  
greater than 2 or for all cluster of several single SNP haplotype separated by one SNP each 
and surrounded by 2 haplotypes of length greater than 2. An example of the genotype 
Imputation and cleaning process can be seen of Figure S2 (panel C). 
The WKY and LEW whole genome sequence data (Illumina HiSeq 2000; at least 10X 
coverage for both strains as described in (Atanur et al., 2013)) was then used to define the 
WKY and LEW allele at each individual SNP. SNPs where the WKY and LEW alleles could 
not be determined from the sequencing data were discarded resulting in 278,124 SNPs that 
can discriminate both alleles. Frequency of the WKY and LEW alleles across the whole 
genome can be seen in Figure S2 (panel D). SNPs where the BRLMM clustering was not 
consistent with the breeding strategy (Heterozygous frequency < 0.35 or >0.65, presence of 
Lewis homozygous genotypes) were discarded leading to a final number of 242,252 SNPs. 
Missing genotypes were then imputed using fastPhase with the 2 founder haplotypes (Figure 
S2). The total number of SNPs for eQTL analysis were 1,974 following removal of those in 
complete linkage disequilibrium (r2=1).  The distribution of Identity by Sharing (IBS) was 
verified in all BC animals and confirmed the absence of any population structure (shown in 
Figure S2, panel E). 
Primary macrophage, osteoclast cultures and assessment of cell multinucleation 
Rat bone marrow derived macrophages (BMDMs) were cultured as previously described 
(Behmoaras et al., 2010). BMDMs were flushed from femur and tibia bones from rats and 
cultured in presence of L929-conditioned media for 4 days. To assess spontaneous MGC 
formation, macrophages were first dissociated using non enzymatic cell dissociation buffer 
(Sigma) and re-plated in Lab-Tek chambers (Fisher Scientific, UK). MGCs were then fixed at 
day 5 using Reastain Quick Diff and MGC quantification was performed by counting the 
number of nuclei in 100 macrophages using light microscopy. In some experiments TRAM-
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differentiation to assess the effect of Kcnn4 blockade on macrophage multinucleation and 
MGC formation. Bone marrow-derived osteoclasts were generated from four- to twelve-week 
old Kcnn4+/+ and Kcnn4-/- mice as previously described (Cui et al., 2007). Bone marrow cells 
were isolated, mechanically dissociated and cultured at a density of 1.33 x 106 cells per cm2 
in a-MEM containing 10% heat inactivated FBS, 100 units/ml penicillin-streptomycin 
(Invitrogen, Carlsbad, CA), 1% MEM vitamins, 1 mM glutamine, and 5 to 30 ng/ml M-CSF 
(R&D, Minneapolis, MN). RANKL (R&D) was added at a concentration of 7 or 40 ng/ml. 
Culture medium was refreshed every three days. At the end of the culture, cells were fixed 
and reacted for tartrate-resistant acid phosphatase according to the supplier’s directions. 
TRAP-positive cells with 3 nuclei or more were counted as osteoclasts as previously 
described (Li et al., 2005). Human monocyte derived macrophages were differentiated from 
buffy coats from healthy donors using gradient separation (Histopaque 1077, Sigma) and 
adhesion purification. Following Histopaque separation, peripheral blood mononuclear cells 
were re-suspended in RPMI (Life Technologies) and monocytes were purified by adherence 
for 1h at 37ºC, 5% CO2. The monolayer was washed 6 times with HBSS to remove non-
adherent cells and monocytes were matured for 5 days in RPMI containing 100 ng/ml M-CSF 
(PeproTech, UK). Macrophage purity was confirmed by immunohistochemical assessment of 
CD68 and > 99% cells were CD68+. In some experiments human peripheral blood 
monocytes were obtained from AllCells LLC (Emeryville, CA). Human osteoclasts were 
generated from normal peripheral blood monocytes or positively selected normal peripheral 
blood CD14+ cells (AllCells, Emeryville, CA). Peripheral blood monocytes were isolated 
using Ficoll-Paque and cultured at a concentration of 3 x 106 cells/ml in low glucose DMEM 
supplemented with 10% fetal bovine serum (FBS; Gemini Bio-Products, NC), recombinant 
human M-CSF (20 ng/ml) and recombinant human RANKL (10 ng/ml). The medium was 
refreshed twice a week. At the end of the culture, the cells were fixed and reacted for tartrate-	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resistant acid phosphatase according to the supplier’s directions. TRAP-positive cells with 3 
nuclei or more were counted as osteoclasts. 
eQTL analysis, network inference and cell type enrichment analysis 
A transcript was designated as an eQTL when it mapped with a probability of 0.8 to a 
genomic region of less than 10 Mb. When multiple SNPs are located within the 10 Mb 
window, we referred to the SNP with the best marginal probability in that region as the 
associated SNP. We defined eQTL hotspots as SNPs linked to a significant over-
representation of trans eQTLs by assuming that each of the 1071 trans eQTLs is associated at 
random to one of the 1974 haplotype tagging SNPs. The number of transcripts associated to a 
SNP follows a binomial distribution with parameters (1071, 1/1974). The Bonferroni-
corrected 95% upper limit of the expected number of associated transcripts at each position, 
is then obtained by taking the αth upper quantile of the distribution with α = 0.05/1974. A 
trans eQTL hotspot is defined by any SNP associated to more than 5 transcripts. eQTL 
hotspots located in the same LD block (r2>0.8) were grouped and the trans cluster is defined 
as the whole set of transcripts mapping in trans to the LD block. 
The network shown in Figure 1C was built by first extracting gene expression from the 184 
genes of the network (190 transcripts) and adjusting the gene expression for the effect of cis-
regulatory SNPs. R package minet was used to compute the mutual information between all 
pairs of gene as well as between all pair of genes and the chromosome 9 locus SNP, and 
ARACNE (Basso et al., 2005) was used to remove indirect edges from the network. Cell type 
enrichment analysis was performed using the Mouse GNF1M Gene Atlas data (GSE1133), 
containing expression from 78 tissues and cell types. Log transformed normalized expression 
was used and for each gene g and cell type c, a Z-score was computed to measure the relative 
overexpression of gene g in cell type c compared to other cell types. Each Z-score was then 
assigned a P-value for significance of the overexpression assuming normal distribution of the 	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Z-scores. Finally, for each cell type, enrichment of the network was computed by counting 
the number of genes with a significant P-values at a marginal 0.05 level, inside and outside of 
the network and using an hypergeometric test for enrichment. 
LPS-induced calvarial bone resorption assay 
To assess osteoclast formation and activity in vivo, we administered a single local 
subperiosteal calvarial injection of LPS (25 µg in 2 µl; Escherichia coli O55:B5, Sigma 
Chemical, St. Louis, MO) to 8-week-old male and female wild type and Kcnn4-/- mice that 
were sacrificed 5 days later. Because the angle of the needle is kept fixed during the injection, 
the osteoclast pits tend to remain in the vicinity of the injected site. Animals were checked 
daily for the five-day duration of the experiment, including weekends and holidays, when 
applicable. Those animals showing evidence of pain, were administered analgesics based on 
consultation with a veterinarian. Calvariae were subjected to microCT analysis, and resorbed 
areas were quantified using ImageJ software (NIH, Bethesda, MD). All procedures were 
approved by the Yale University Institutional Animal Care and Use Committee. 
Measurement of bone turnover markers 
Serum samples were obtained from Kcnn4+/+ and Kcnn4-/- mice at sacrifice in control and 
following CAIA and were stored at −80 °C. N-terminal propeptide of type 1 procollagen 
(P1NP) and C-terminal cross-linked telopeptide of type I collagen (CTX) levels were 
determined by enzyme immunoassay using IDS kits AC-33F1 and AC-06F1, respectively 
(Immunodiagnostic Systems). 
RNA-seq library preparation and data analysis in primary macrophages 
Total RNA was extracted from WKY macrophages (+/- TRAM-34, 10µM) using Trizol 
(Invitrogen) according to manufacturer's instructions with an additional purification step by 
on-column DNase treatment using the RNase-free DNase Kit (Qiagen) to ensure elimination 
of any genomic DNA. The integrity and quantity of total RNA was determined using a 	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NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific) and Agilent 2100 Bioanalyzer 
(Agilent Technologies). 1µg of total RNA was used to generate RNA-seq libraries using 
TruSeq RNA sample preparation kit (Illumina) according to the manufacturer's instructions. 
Briefly, RNA was purified and fragmented using poly-T oligo-attached magnetic beads using 
two rounds of purification followed by the first and second cDNA strand synthesis. Next, 
cDNA 3' ends were adenylated and adapters ligated followed by 10 cycles of library 
amplification. Finally, the libraries were size selected using AMPue XP Beads (Becmkan 
Coulter) purified and their quality was checked using Agilent 2100 Bioanalyzer. Samples 
were randomized to avoid batch effects and libraries were run on a single lane per sample of 
the HiSeq 2000 platform (Illumina) to generate 75bp paired-end reads. RNA-seq reads were 
then aligned to the rn4 reference genome using tophat 2 and non-uniquely aligned reads 
where discarded leading to coverage of ~40M reads and 35M uniquely mapped reads. Gene 
level read counts were computed using HT-Seq and genes with less that 10 aligned reads 
across all samples were discarded prior to analysis leading to 15,155 genes. Differential 
expression analyses between the two groups were carried out using edgeR and using a 5% 
FDR to call significant differentially expressed genes.  Cell type enrichment analysis was 
performed using the Mouse GNF1M Gene Atlas data (GSE1133), containing expression from 
78 tissues and cell types. Log transformed normalized expression was used and for each gene 
g and cell type c, a Z-score was computed to measure the relative overexpression of gene g in 
cell type c compared to other cell types. Each Z-score was then assigned a P-value for 
significance of the over-expression assuming normal distribution of the Z-scores. For each 
cell type, enrichment of the set of differentially expressed genes was computed by counting 
the number of genes with significant P-values at a marginal 0.05 level, inside and outside of 
the set of differentially expressed genes and using an hypergeometric test for enrichment. 	   6	  
 
siRNA and qRT-PCR 
On day 5 of culture, WKY BMDMs were replated in six-well plates (1x106 cells per well) in 
DMEM (Invitrogen) overnight and transfected for 48 hours with siGENOME SMARTpool 
for either human or rat Trem2, and rat Treml1, Trem1, D3ZDX3_Rat (100 nM, Dharmacon) 
or siGENOME non-targeting siRNA pool as the scrambled control siRNA using Dharmafect 
1 (1:50, Dharmacon) as a transfection reagent in OPTIMEM medium (Invitrogen). For 
human monocytes-derived macrophages (MDMs), cells were incubated on day 5 of cluture 
with either human TREM2 siRNA or siGENOME non-targeting siRNA pool. The siRNA 
sequences used in the siGENOME SMARTpool for all transcripts are available upon request. 
All qRT-PCRs were performed with an ABI 7900 Sequence Detection System (Applied 
Biosystems, Warrington, UK). A two-step protocol was used beginning with cDNA synthesis 
with iScript select (Bio-Rad) followed by PCR using SYBR Green Jumpstart Taq Ready Mix 
(Sigma). A total of 10ng of cDNA per sample was used. All samples were amplified using a 
set of 4 biological replicates with three technical replicates used per sample in the PCR 
analysis. Sequence detection software (SDS) version (Applied Biosystems) was used to 
obtain the Ct values. Results were analysed using the comparative Ct method and each 
sample was normalised to the reference gene Hprt, to account for any cDNA loading 
differences. The primer sequences are available upon request.  
Histomorphometric analysis of the bone 
Histomorphometry was performed 0.25 mm proximal to the growth plate using Osteomeasure 
software (Osteometrics, Atlanta, GA). The following parameters were measured: the relative 
tissue surface occupied by bone (B.Ar/T.Ar; %); the number of trabeculae per mm (Tb.N 
/mm); the relative surface of bone occupied by trabeculae (Tb.Ar; %); the distance/separation 
between trabeculae (µm); the number of osteoclasts per total bone surface (Oc/T.Ar); the 
perimeter of osteoclasts per total bone perimeter (Oc.Pm./B.Pm); the perimeter of osteoblasts 	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per total bone perimeter (Ob.Pm/B.Pm), mineralizing surface (MS/BS), mineral apposition 
rate (MAR), and bone formation rate (BFR/BV). 
Scoring and histopathological evaluation of collagen antibody-induced arthritis (CAIA) 
The scoring system for CAIA was 0 = normal; 1 = erythema and edema in 1-2 digits; 2 = 
erythema and edema in >2 digits or mild erythema and edema, usually in the ankle joint; 3 = 
moderate erythema and edema encompassing the tarsal joint; 4 = severe erythema and edema 
encompassing the tarsal and metatarsal joint. This analysis was completed by Bolder BioPath 
(Boulder, Co). Formalin fixed joints (right and left fore and hind paws, both ankles and both 
knees) were decalcified in 5% formic acid for 2-3 days; tissues were trimmed, processed for 
paraffin embedding, sectioned at 8 µm and stained with toluidine blue. Both hind paws, both 
fore paws, and both knees were embedded and sectioned in the frontal plane while ankles 
were sectioned in the sagittal plane or ankles may be sectioned with hind paws in the frontal 
plane. All sections were scored without knowledge of the treatment groups. Groups were 
later identified as follows. When scoring paws or ankles from mice with arthritic lesions, 
severity of changes as well as number of individual joints affected were recorded. When only 
1-3 joints of the paws or ankles out of a possibility of numerous metacarpal/metatarsal/digit 
or tarsal/tibio-tarsal joints were affected, an arbitrary assignment of a maximum score of 1, 2 
or 3 for parameters below was given depending on severity of changes. If more than 3 joints 
were involved, the criteria below were applied to the most severely affected/majority of 
joints. Inflammation: 0 = Normal; 1 = Minimal infiltration of inflammatory cells in synovium 
and periarticular tissue of affected joints; 2 = Mild infiltration of inflammatory cells. If 
referring to paws, generally restricted to affected joints (1-3 affected); 3 = Moderate 
infiltration with moderate edema. If referring to paws, restricted to affected joints, generally 
3-4 joints + wrist or ankle; 4 = Marked infiltration affecting most areas with marked edema, 1 
or 2 unaffected joints may be present; 5 = Severe diffuse infiltration with severe edema 	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affecting all joints and periarticular tissues. Pannus: 0 = Normal; 1 = Minimal infiltration of 
pannus in cartilage and subchondral bone, marginal zones; 2 = Mild infiltration with marginal 
zone destruction of hard tissue in affected joints; 3 = Moderate infiltration with moderate 
hard tissue destruction in affected joints; 4 = Marked infiltration with marked destruction of 
joint architecture, affecting most joints; 5 = Severe infiltration associated with total or near 
total destruction of joint architecture, affects all joints. Cartilage Damage: 0 = Normal; 1 = 
Minimal = generally minimal to mild loss of toluidine blue staining with no obvious 
chondrocyte loss or collagen disruption in affected joints; 2 = Mild = generally mild loss of 
toluidine blue staining with focal areas of chondrocyte loss and/or collagen disruption in 
some affected joints; 3 = Moderate = generally moderate loss of toluidine blue staining with 
multifocal chondrocyte loss and/or collagen disruption in affected joints, some matrix 
remains on any affected surface with areas of severe matrix loss; 4 = Marked = marked loss 
of toluidine blue staining with multifocal marked (depth to deep zone) chondrocyte loss 
and/or collagen disruption in most joints, if knee-one surface with total to near total cartilage 
loss; 5 = Severe = severe diffuse loss of toluidine blue staining with multifocal severe (depth 
to tide mark) chondrocyte loss and/or collagen disruption in all joints, if knee-2 or more 
surfaces with total to near total cartilage loss. Bone Resorption: 0 = Normal; 1 = Minimal = 
small areas of resorption, not readily apparent on low magnification, rare osteoclasts in 
affected joints, restricted to marginal zones; 2 = Mild = more numerous areas of resorption, 
not readily apparent on low magnification, osteoclasts more numerous in affected joints, 
restricted to marginal zones; 3 = Moderate = obvious resorption of medullary trabecular and 
cortical bone without full thickness defects in cortex, loss of some medullary trabeculae, 
lesion apparent on low magnification, osteoclasts more numerous in affected joints; 4 = 
Marked = full thickness defects in cortical bone, often with distortion of profile of remaining 
cortical surface, marked loss of medullary bone, numerous osteoclasts, affects most joints; 5 	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= Severe = full thickness defects in cortical bone and destruction of joint architecture of all 
joints.  For each animal, the inflammation, pannus, cartilage damage and bone damage scores 
were determined for each of the 8 joints submitted. A sum total (all 8 joints) animal score and 
an eight joint mean animal score was determined as well as sums and means for each of the 
individual parameters. Parameters for the various groups were then compared with Group A 
(vehicle) using a Student’s t-test or other appropriate analysis methods with significance set 
at p ≤ 0.05. 
Calcium oscillations and electrophysiology 
Bone marrow-derived macrophages isolated from Kcnn4+/+ and Kcnn4-/- mice were plated on 
12-mm diameter coverglass that were placed in 24-well dishes. Cells were cultured in the 
presence of M-CSF (25 ng/ml) supplemented or not with RANKL (10 ng/ml). Oscillations 
were recorded 3 days later. Cells were incubated for 30 minutes at 30°C in loading solution 
(115 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM HEPES, and 10 mM 
glucose, pH 7.42) supplemented with 5 µM Fura-2/AM (Invitrogen). Fura-2 fluorescent 
images were analyzed using an inverted microscope (ECLIPSE TE300, Nikon) and a video 
image analysis system (Argus-50/CA, Hamamatsu Photonics) with excitation filters at 340 
±10 and 380 ± 10 nm, a dichroic beam splitter at 400 nm, and a bandpass emission filter at 
510–550 nm. The recording solution contained 115 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 
mM CaCl2, 20 mM HEPES, and 10 mM glucose, pH 7.42. Data are presented as mean ± 
standard error of the mean (SEM) and statistical significance was determined using the 
Student’s t-test.  
Electrophysiology 
For electrophysiology, macrophages plated on 12-mm diameter coverslips were transferred to 
a recording chamber and superfused (~1 ml/min) with external solution: 145 mM NaCl, 5 
mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 2.5 mM Glucose, pH 7.4. Pipettes 	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had a resistance of 3-9 MΩ when filled with internal solution: 120 mM KCl, 2 mM MgCl2, 
10 mM HEPES, 20 mM glucose, 10 mM EGTA, pH 7.3. To achieve a free internal Ca2+ 
concentration of 10-6 M in the presence of 10 mM EGTA, 8.98 mM CaCl2 was added to the 
internal solution (23). In some experiments, 1 µM ICA-1703 was included in the external 
solution. Experiments were performed using an upright microscope (Olympus BX51WI, 
Olympus, Center Valley, PA) under phase-contrast optics (60x objective, NA 0.9) and at 
room temperature. An Axopatch 200B patch clamp amplifier, Digidata 1322A digitizer, and 
PClamp9 software (Axon Instruments, CA) were used for recordings (2 kHz low-pass 
filtered; 5 kHz sampling rate). Cells were maintained at a holding potential of -60 mV. 
Voltage steps from -100 mV to + 80 mV (400 ms) and voltage ramps (-140 mV to +120 mV 
over 200 ms) were applied to generate current / voltage plots in Clampfit 9.0 (Axon 
Instruments, CA). 
Immunohistochemistry and Immunofluorescence 
For ED-1 (AbD Serotec, Oxford, UK) immunostaining, formalin-fixed, paraffin-embedded 
rat tissues were microwaved in sodium citrate buffer for antigen retrieval. Following 
consecutive blocking steps (peroxide block for 15 min, 10% goat serum block for 15 min, 
followed by a 10% milk block for 15 min), sections were incubated with the primary 
antibody ED-1 (1:500) and the slides left for 1 h at room temperature. The slides were then 
washed and incubated in the polymer-HRP (Dako mouse EnVision kit, Dako, Denmark) for 
30 min at room temperature. Staining was visualized using DAB (Dako EnVision kit) and 
sections counterstained with hematoxylin, dehydrated, and mounted with cover slips. For 
visualization of the acting cytoskeleton and nuclei, cells were fixed in 4% paraformaldehyde 
(PFA) for 20 minutes at room temperature and stained with rhodamine-phalloidin (Molecular 
Probes, Eugene, OR, USA) and 4′,6-diamidino-2-phenylindole (DAPI; Sigma ) as described 
(MacLauchlan et al., 2009).  	   11	  
Western Blotting 
After four to seven days of culture, osteoclasts were serum-starved for three to four hours and 
stimulated with the indicated reagents. The cells were then lysed in Laemmli sample buffer 
supplemented with protease inhibitors (cOmpleteTM protease inhibitor tablets; Roche 
Molecular Biochemicals), sodium fluoride, and a phosphatase inhibitor cocktail II (Roche). 
The lysates were sonicated and resolved by SDS-PAGE, transferred to PVDF membranes, 
and subjected to immunoblotting with appropriate primary and secondary antibodies. The 
probed proteins were detected using SuperSignal West Femto Cheluminescent Substrate 
(Thermo Fisher Scientific Inc., Rockford, IL). 
Statistical Analysis 
Unless otherwise stated, data represent the mean ± one standard deviation (SD). Treatment 
groups were compared using the analysis of variance. Unless otherwise stated, pairwise 
comparison p-values between the treatment groups were adjusted using Tukey multiple 
comparison procedure. Statistical significance was declared if the two-sided p-value is < 
0.05.  
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